IN8bio, Inc.
INAB
$0.1449
$0.01219.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 35.18% | 18.93% | 1.16% | -11.85% | -13.78% |
| Total Depreciation and Amortization | 5.85% | 11.96% | 6.65% | -0.94% | 7.12% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -32.98% | -34.11% | 45.89% | 14.92% | 44.35% |
| Change in Net Operating Assets | 175.51% | -30.38% | -253.60% | 2.08% | 9.83% |
| Cash from Operations | 60.58% | 16.95% | -6.97% | -14.11% | -6.45% |
| Capital Expenditure | -- | 54.17% | 100.00% | -277.27% | 83.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 54.17% | 100.00% | -277.27% | 83.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -19.68% | -26.59% | 9.75% | 18.69% | -7.43% |
| Issuance of Common Stock | -- | -17.01% | -84.69% | -69.65% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,505.42% | -16.21% | -106.36% | -70.60% | -150.64% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 109.33% | -15.47% | -50.22% | -145.57% | -12.92% |